Home » Topics » Disease categories and therapies » Urology

Urology
RSS

FDA accepts for review sNDA for mirabegron in combination with solifenacin for overactive bladder

Sep. 14, 2017

Bayer enters kidney disease collaboration with Vanderbilt University Medical Center

Sep. 12, 2017

MK-3866 studied in patients with impaired renal function

Sep. 12, 2017

Avadel enters license agreement for U.S. and Canadian rights to Noctiva

Sep. 6, 2017

Enrollment completed in phase IIb study of BGS-649 for hypogonadotropic hypogonadism

Sep. 5, 2017

Taisho Pharmaceutical presents 20-HETE synthase inhibitors

Sep. 1, 2017

Apricus resubmits Vitaros NDA

Aug. 30, 2017

Anthera reports topline data from BRIGHT-SC extension of blisibimod in IgA nephropathy

Aug. 30, 2017

Roche discloses new DDR1 inhibitors

Aug. 28, 2017

Lilly discovers novel phosphodiesterase PDE1 inhibitors

Aug. 25, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.